Effect of zinc binding residues in growth hormone (GH) and altered intracellular zinc content on regulated GH secretion

Endocrinology

Volumn 154, Issue 11, 2013, Pages 4215-4225

  Petkovic, Vibor ^a   Miletta, Maria Consolata ^a   Eblé, Andrée ^a   Iliev, Daniel I ^b   Binder, Gerhard ^b   Flück, Christa E ^a   Mullis, Primus E ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ETHYLENEDIAMINE DERIVATIVE; FORSKOLIN; GROWTH HORMONE; N,N,N',N' TETRAKIS(2 PYRIDYLEMETHYL)ETHYLENEDIAMINE; UNCLASSIFIED DRUG; ZINC;

ANIMAL CELL; ARTICLE; CONFOCAL MICROSCOPY; CULTURE MEDIUM; GENE; GENE MUTATION; GROWTH HORMONE 1 GENE; GROWTH HORMONE RELEASE; HYPOPHYSIS CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; APOPTOSIS; CELL LINE; CELL SURVIVAL; CULTURE MEDIA; ETHYLAMINES; GROWTH HORMONE; HUMANS; MICE; MUTATION; PROTEIN BINDING; PYRIDINES; RATS; TIME FACTORS; ZINC;

EID: 84886500859     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2013-1089     Document Type: Article

References (34)

1. Eide DJ. Zinc transporters and the cellular trafficking of zinc. Biochim Biophys Acta. 2006;1763(7): 711-722.
2. Berg JM, Shi Y. The galvanization of biology: a growing appreciation for the roles of zinc. Science. 1996;271(5252): 1081-1085.
3. Coleman JE. Zinc enzymes. Curr Opin Chem Biol. 1998;2(2): 222-234.
4. Vallee BL, Falchuk KH. The biochemical basis of zinc physiology. Physiol Rev. 1993;73(1): 79-118.
5. Stumm W, Morgan JJ. Aquatic Chemistry: Chemical Equilibria and Rates in Natural Waters. 3rd ed. New York: Wiley-Interscience; 1996.
6. Bozym RA, Thompson RB, Stoddard AK, Fierke CA. Measuring picomolar intracellular exchangeable zinc in PC-12 cells using a ratiometric fluorescence biosensor. ACS Chem Biol. 2006;1(2): 103-111.
7. Outten CE, O'Halloran TV. Femtomolar sensitivity of metalloregu-latory proteins controlling zinc homeostasis. Science. 2001; 292(5526): 2488-2492.
8. Thorlacius-Ussing O. Zinc in the anterior pituitary of rat: a histochemical and analytical work. Neuroendocrinology. 1987;45(3): 233-242.
9. Farquhar MG, Wellings SR. Electron microscopic evidence suggesting secretory granule formation within the Golgi apparatus. J Biophys Biochem Cytol. 1957;3(2): 319-322.
10. Dannies PS. Mechanisms for storage of prolactin and growth hormone in secretory granules. Mol Genet Metab. 2002;76(1):6-13.
11. Keeler C, Hodsdon ME, Dannies PS. Is there structural specificity in the reversible protein aggregates that are stored in secretory granules? J Mol Neurosci. 2004;22(1-2): 43-49.
12. Sankoorikal BJ, Zhu YL, Hodsdon ME, Lolis E, Dannies PS. Aggregation of human wild-type and H27A-prolactin in cells and in solution: roles of Zn(2+), Cu(2+), and pH. Endocrinology. 2002; 143(4): 1302-1309.
13. Sun Z, Lee MS, Rhee HK, Arrandale JM, Dannies PS. Inefficient secretion of human H27A-prolactin, a mutant that does not bind Zn2+. Mol Endocrinol. 1997;11(10): 1544-1551.
14. Cunningham BC, Mulkerrin MG, Wells JA. Dimerization of human growth hormone by zinc. Science. 1991;253(5019): 545-548.
15. Sun Z, Li PS, Dannies PS, Lee JC. Properties of human prolactin (PRL) and H27A-PRL, a mutant that does not bind Zn++. Mol Endocrinol. 1996;10(3): 265-271.
16. Miura T, Suzuki K, Kohata N, Takeuchi H. Metal binding modes of Alzheimer's amyloid beta-peptide in insoluble aggregates and soluble complexes. Biochemistry. 2000;39(23): 7024-7031.
17. Permyakov EA, Veprintsev DB, Permyakov SE, et al. pH-induced transition and Zn2+-binding properties of bovine prolactin. FEBS Lett. 1997;405(3): 273-276.
18. Dannies PS. Prolactin and growth hormone aggregates in secretory granules: the need to understand the structure of the aggregate. Endocr Rev. 2012;33(2): 254-270.
19. Nicoll CS, Mayer GL, Russell SM. Structural features of prolactins and growth hormones that can be related to their biological properties. Endocr Rev. 1986;7(2): 169-203.
20. Iliev DI, Wittekindt NE, Ranke MB, Binder G. In vitro analysis of hGH secretion in the presence of mutations of amino acids involved in zinc binding. J Mol Endocrinol. 2007;39(2): 163-167.
21. Tildsley GJ, Dilly SA. Audit of general surgical pathology experience of histopathology trainees. J Clin Pathol. 1991;44(5): 424-427.
22. Besson A, Salemi S, Deladoey J, et al. Short stature caused by a biologically inactive mutant growth hormone (GH-C53S). J Clin Endocrinol Metab. 2005;90(5): 2493-2499.
23. Salemi S, Yousefi S, Lochmatter D, et al. Isolated autosomal dominant growth hormone deficiency: stimulating mutant GH-1 gene expression drives GH-1 splice-site selection, cell proliferation, and apoptosis. Endocrinology. 2007;148(1): 45-53.
24. Salemi S, Yousefi S, Baltensperger K, et al. Variability of isolated autosomal dominant GH deficiency (IGHD II): impact of the P89L GH mutation on clinical follow-up and GH secretion. Eur J Endocrinol. 2005;153(6): 791-802.
25. Ross RJM, Esposito N, Shen X-Y, et al. A short isoform of the human growth hormone receptor functions as a dominant negative inhibitor of the full-length receptor and generates large amounts of binding protein. Mol Endocrinol. 1997;11(3): 265-273.
26. Von Laue S, Finidori J, Maamra M, et al. Stimulation of endogenous GH and interleukin-6 receptors selectively activates different Jaks and Stats, with a Stat5 specific synergistic effect of dexamethasone. Endocrinol. 2000;165: 301-311.
27. Parat MO, Richard MJ, Beani JC, Favier A. Involvement of zinc in intracellular oxidant/antioxidant balance. Biol Trace Elem Res. 1997;60(3): 187-204.
28. Seve M, Favier A, Osman M, et al. The human immunodeficiency virus-1 Tat protein increases cell proliferation, alters sensitivity to zinc chelator-induced apoptosis, and changes Sp1 DNA binding in HeLa cells. Arch Biochem Biophys. 1999;361(2): 165-172.
29. Parat MO, Richard MJ, Pollet S, Hadjur C, Favier A, Beani JC. Zinc and DNA fragmentation in keratinocyte apoptosis: its inhibitory effect inUVBirradiated cells. J Photochem PhotobiolB. 1997;37(1- 2): 101-106.
30. Ahn YH, Kim YH, Hong SH, Koh JY. Depletion of intracellular zinc induces protein synthesis-dependent neuronal apoptosis in mouse cortical culture. Exp Neurol. 1998;154(1): 47-56.
31. Treves S, Trentini PL, AscanelliM,Bucci G, Di Virgilio F. Apoptosis is dependent on intracellular zinc and independent of intracellular calcium in lymphocytes. Exp Cell Res. 1994;211(2): 339-343.
32. Zalewski PD, Forbes IJ, Betts WH. Correlation of apoptosis with change in intracellular labile Zn(II) using zinquin [(2-methyl-8-ptoluenesulphonamido- 6-quinolyloxy)acetic acid], a new specific fluorescent probe for Zn(II). Biochem J. 1993;296(Pt 2): 403-408.
33. Chimienti F, Seve M, Richard S, Mathieu J, Favier A. Role of cellular zinc in programmed cell death: temporal relationship between zinc depletion, activation of caspases, and cleavage of Sp family transcription factors. Biochem Pharmacol. 2001;62(1): 51-62.
34. Petkovic V, Lochmatter D, Turton J, et al. Exon splice enhancer mutation (GH-E32A) causes autosomal dominant growth hormone deficiency. J Clin Endocrinol Metab. 2007;92(11): 4427-4435.